Clinical and pathologic features of fibroadenoma of the mastopathic type

被引:7
作者
Kuroda, H
Takeuchi, I
Ohnishi, K
Sakamoto, G
Akiyama, F
Toyozumi, Y
Momose, S
Tamaru, JI
Itoyama, S
机构
[1] Saitama Med Sch, Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan
[2] Saitama Med Sch, Saitama Med Ctr, Dept Surg, Kawagoe, Saitama 3508550, Japan
[3] Japanese Fdn Canc Res, Canc Inst & Hosp, Dept Breast Pathol, Tokyo, Japan
关键词
fibroadenoma; histologic type; mastopathic;
D O I
10.1007/s00595-006-3206-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. Fibroadenoma with mastopathic change (FAM) is a relatively uncommon subtype of fibroadenoma of the breast, with a high incidence of pathological misdiagnosis. This histological subtype remains poorly understood because of its rarity. Many questions remain unanswered about its clinicopathological importance, especially in the differential diagnosis of breast cancers. Methods. Among 218 breast fibroadenomas surgically resected as excisional biopsies at our institute between 1990 and 2004, 19 were pathologically diagnosed as FAM. We reviewed these 19 patients. Results. The ages of the patients ranged from 20 to 51 years (mean 36.8 years). The tumor sizes ranged from 0.8 to 7cm (mean 2.1cm). Six of the 19 patients underwent core needle biopsy, resulting in a diagnosis of fibroadenoma in four patients and atypical ductal hyperplasia in two patients. Ultrasonography showed findings suggestive of solid tubular carcinoma in seven patients, fibroadenoma in ten patients, and unspecific malignant tumors in two. They were not specified clinically. Conclusion. Recognition of this distinctive variant of fibroadenoma is important because it resembles intraductal carcinoma and is increasing in incidence. It is crucial to distinguish FAM from intraductal carcinoma in biopsy specimens. Thus, not only pathologists but also clinicians must be able to recognize this type of fibroadenoma, and cooperate closely to establish an accurate diagnosis.
引用
收藏
页码:590 / 595
页数:6
相关论文
共 14 条
[1]  
Carter BA, 2001, CANCER, V92, P30, DOI 10.1002/1097-0142(20010701)92:1<30::AID-CNCR1288>3.0.CO
[2]  
2-2
[3]   RISK-FACTORS FOR BREAST-CANCER IN WOMEN WITH PROLIFERATIVE BREAST DISEASE [J].
DUPONT, WD ;
PAGE, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) :146-151
[4]   LONG-TERM RISK OF BREAST-CANCER IN WOMEN WITH FIBROADENOMA [J].
DUPONT, WD ;
PAGE, DL ;
PARL, FF ;
VNENCAKJONES, CL ;
PLUMMER, WD ;
RADOS, MS ;
SCHUYLER, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (01) :10-15
[5]  
HAAGENSEN CD, 1986, DISEASES BREAST, P267
[6]  
*JAP BREAST CANC S, 2004, GEN RUL CLIN PATH RE
[7]  
Kinoshita S, 1991, JPN J BREAST CANC, V6, P377
[8]  
Kuijper A, 2001, AM J CLIN PATHOL, V115, P736
[9]  
PAGE DL, 1987, DIAGNOSTIC HISTOPATH, P72
[10]  
Rosen PP, 2001, ROSENS BREAST PATHOL, P163